Cronyism Blocks Another Affordable COVID Med
(From The Alliance for Natural Health)
The Frontline COVID-19 Critical Care Alliance (FLCCC) published a paper reviewing the evidence for ivermectin, an off-patent drug for river blindness, arguing that it has antiviral and anti-inflammatory properties that make it effective in the prevention and treatment of COVID. The evidence on ivermectin is, unsurprisingly, being ignored by the medical establishment because it is a cheap drug and can’t make boatloads of money for drug companies—much like hydroxychloroquine.
This article was originally posted here: https://www.ac2news.com/2021/02/cronyism-blocks-another-affordable-covid-med/.